# FDA 483 - Merrill D. Benson, M.D. - December 03, 2018

Source: https://www.globalkeysolutions.net/records/483/merrill-d-benson-md/cdfc6168-bded-4fcf-ba15-4f4cf6318114

> FDA 483 for Merrill D. Benson, M.D. on December 03, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Merrill D. Benson, M.D.
- Inspection Date: 2018-12-03
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations III
- Summary: An FDA inspection of Merrill D. Benson, M.D., a Sponsor-Investigator in Indianapolis, revealed significant issues in conducting a clinical investigation. The firm failed to adhere to the investigational plan regarding platelet monitoring for study subjects and did not notify the FDA about a change in the Principal Investigator for a study. These issues were noted as repeat observations from a previous inspection.

## Related Officers

- [U.S. Food and Drug Administration](https://www.globalkeysolutions.net/people/myra-k-casey/a2fae714-2ba3-4c60-9f54-990fc7b169c9)

Company: https://www.globalkeysolutions.net/companies/merrill-d-benson-md/0375e6c9-23ce-4473-aed5-dd931508279c

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iii/45bc2d0d-d731-4955-aeb5-59aa0b76e4f0